Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nature cell biology. 2015;17(3):288–99. https://doi.org/10.1038/ncb3114.
Article CAS PubMed PubMed Central Google Scholar
Koprich JB, Kalia LV, Brotchie JM. Animal models of α‑synucleinopathy for Parkinson disease drug development. Nature Reviews Neuroscience. 2017;18(9):515–29. https://doi.org/10.1038/nrn.2017.75.
Article CAS PubMed Google Scholar
Wang C, Niederstrasser H, Douglas PM, Lin R, Jaramillo J, Li Y, Oswald NW, Zhou A, McMillan EA, Mendiratta S, Wang Z. Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun. 2017;8(1)2270. https://doi.org/10.1038/s41467-017-02332-3.
Article CAS PubMed PubMed Central Google Scholar
Santulli G, Totary-Jain H. Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics. 2013;14(12):1517–26. https://doi.org/10.2217/pgs.13.143.
Article CAS PubMed PubMed Central Google Scholar
Zhuang XX, Wang SF, Tan Y, Song JX, Zhu Z, Wang ZY, Wu MY, Cai CZ, Huang ZJ, Tan JQ, Su HX. Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson’s disease models. Cell Death Discov. 2020;11(2)128. https://doi.org/10.1038/s41419-020-2322-6.
Singh B, Mahajan S, Abdella S, Khan R, Garg S. Exploring autophagy inducing molecules: targeting diverse pathways in alzheimer’s disease management. Med Res Rev. 2025; https://doi.org/10.1002/med.70013.
Article PubMed PubMed Central Google Scholar
Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D, Venditti R, Montefusco S, Scotto-Rosato A, Prezioso C, Forrester A, Settembre C. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nature cell biology. 2015;17(3):288–99. https://doi.org/10.1038/ncb3114.
Article CAS PubMed PubMed Central Google Scholar
Chen H, Gong S, Zhang H, Chen Y, Liu Y, Hao J, Liu H, Li X. From the regulatory mechanism of TFEB to its therapeutic implications. Cell Death Discov. 2024;10(1):84–84. https://doi.org/10.1038/s41420-024-01850-6.
Article CAS PubMed PubMed Central Google Scholar
Cui M, Yamano K, Yamamoto K, Yamamoto-Imoto H, Minami S, Yamamoto T, Matsui S, Kaminishi T, Shima T, Ogura M, Tsuchiya M. HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence. PNAS Nexus. 2024;121(2)e2306454120. https://doi.org/10.1073/pnas.2306454120.
Torra A, Parent A, Cuadros T, Rodríguez-Galván B, Ruiz-Bronchal E, Ballabio A, Bortolozzi A, Vila M, Bové J. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration. Mol Ther. 2018;26(6):1552–67. https://doi.org/10.1016/j.ymthe.2018.02.022.
Article CAS PubMed PubMed Central Google Scholar
Su CJ, Shen Z, Cui RX, Huang Y, Xu DL, Zhao FL, Pan J, Shi AM, Liu T, Yu YL. Thioredoxin-interacting protein (TXNIP) regulates Parkin/PINK1-mediated mitophagy in dopaminergic neurons under high-glucose conditions: implications for molecular links between Parkinson’s disease and diabetes. Neurosci Bull. 2020;36(4):346–58. https://doi.org/10.1007/s12264-019-00459-5.
Article CAS PubMed PubMed Central Google Scholar
Franco-Juárez B, Coronel-Cruz C, Hernández-Ochoa B, Gómez-Manzo S, Cárdenas-Rodríguez N, Arreguin-Espinosa R, Bandala C, Canseco-Ávila LM, Ortega-Cuellar D. TFEB; beyond its role as an autophagy and lysosomes regulator. Cells. 2022;11(19)3153. https://doi.org/10.3390/cells11193153.
Article CAS PubMed PubMed Central Google Scholar
Moors TE, Hoozemans JJ, Ingrassia A, Beccari T, Parnetti L, Chartier-Harlin MC, Van De Berg WD. Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease. Mol Neurodegener. 2017;12(1)11. https://doi.org/10.1186/s13024-017-0154-3.
Article CAS PubMed PubMed Central Google Scholar
Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annual review of cell and developmental biology. 2016;32(1):255–78. https://doi.org/10.1146/annurev-cellbio-111315-125407.
Article CAS PubMed PubMed Central Google Scholar
Sahoo S, Padhy AA, Kumari V, Mishra P. Role of ubiquitin–proteasome and autophagy-lysosome pathways in α‑synuclein aggregate clearance. Mol Neurobiol. 2022;59(9):5379–407. https://doi.org/10.1007/s12035-022-02897-1.
Article CAS PubMed Google Scholar
Pinheiro PD, Diniz LP, Franco LS, Siqueira M, Gomes FC. Histone Deacetylases in Neurodegenerative Diseases and Their Potential Role as Therapeutic Targets: Shedding Light on Astrocytes. Pharmaceuticals. 2025;18(10)1471. https://doi.org/10.3390/ph18101471.
Article CAS PubMed PubMed Central Google Scholar
Torra A, Parent A, Cuadros T, Rodríguez-Galván B, Ruiz-Bronchal E, Ballabio A, Bortolozzi A, Vila M, Bové J. Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents Parkinson’s disease-related neurodegeneration. Mol Ther. 2018;26(6):1552–67. https://doi.org/10.1016/j.ymthe.2018.02.022.
Article CAS PubMed PubMed Central Google Scholar
Song TT, Cai RS, Hu R, Xu YS, Qi BN, Xiong YA. The important role of TFEB in autophagy-lysosomal pathway and autophagy-related diseases: a systematic review. European Review for Medical Pharmacological Sciences. 2021; https://doi.org/10.26355/eurrev_202102_24875.
Zwakenberg S, Westland D, van Es RM, Rehmann H, Anink J, Ciapaite J, Bosma M, Stelloo E, Liv N, Alcaraz PS, Verhoeven-Duif NM. mTORC1 restricts TFE3 activity by auto-regulating its presence on lysosomes. Mol Cell. 2024;84(22):4368–84. https://doi.org/10.1016/j.molcel.2024.10.009.
Article CAS PubMed Google Scholar
Corà D, Bussolino F, Doronzo G. TFEB signalling-related MicroRNAs and autophagy. Biomolecules. 2021;11(7)985. https://doi.org/10.3390/biom11070985.
Article CAS PubMed PubMed Central Google Scholar
Ballabio A, Bonifacino JS. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol. 2020; https://doi.org/10.1038/s41580-019-0185-4.
Bayati A, McPherson PS. alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions. J Biol Chem. 2024;107742. https://doi.org/10.1016/j.jbc.2024.1077422.
Brady OA, Martina JA, Puertollano R. Emerging roles for TFEB in the immune response and inflammation. Autophagy Rep. 2018;14(2):181–9. https://doi.org/10.1080/15548627.2017.13139433.
Article CAS PubMed Google Scholar
Bridi JC, Hirth F. Mechanisms of α‑synuclein-induced synaptopathy in Parkinson’s disease. Front Neurosci. 2018;12:80. https://doi.org/10.3389/fnins.2018.000800.
Article PubMed PubMed Central Google Scholar
Buratta S, Tancini B, Sagini K, Delo F, Chiaradia E, Urbanelli L, Emiliani C. Lysosomal exocytosis, exosome release and secretory autophagy: the autophagic-and endo-lysosomal systems go extracellular. International Journal of Molecular Sciences. 2020;21(7)2576. https://doi.org/10.3390/ijms21072576.
Article CAS PubMed PubMed Central Google Scholar
Cao B, Chen X, Li Y, Zhou T, Chen N, Guo Y, Zhao M, Guo C, Shi Y, Wang Q, Du X. PDCD4 triggers α‑synuclein accumulation and motor deficits via co-suppressing TFE3 and TFEB translation in a model of Parkinson’s disease. NPJ Parkinsons Dis. 2024;10(1)146. https://doi.org/10.1038/s41531-024-00760-99.
Comments (0)